Viking Therapeutics, Inc. (VKTX) — research page

US · us-cm-kg/NASDAQ/VKTX · as of 2026-11-08

Identity and listing

The issuer is Viking Therapeutics, Inc., listed on NASDAQ under ticker VKTX, with ISIN US92686J1060 and LEI 529900IVC72YPFA25M37. Its security type is Corporate, its segment is not on the record, its sector is 2834 Pharmaceutical Preparations, and its jurisdiction is United States, Delaware. Its listing status is listed, not halted.

The disclosure read

The record holds 49 filings in the twelve months to 2026-11-08, across 22 filing days. The median gap between filing days is 8 days. The latest filing is dated 2026-11-05, 3 days before the record date, and is of type regulatory filing. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days, and a latency of 5.0 days. The 2834 Pharmaceutical Preparations sector median is 63.0 filings, a cadence gap of 6.0 days, and a latency of 4.0 days.

window 2025-11-08 to 2026-11-08 · the node's disclosure lines, as get_filings serves them

Auditor

The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes.

Events and halts

The record holds no listing, delisting or name change lines. The domicile change is not on the record, because EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, because the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted.

Orderability

The outcome is not determinable, because the chapter's orderability section carries no client categories and so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04.

rule acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1 · chapter as of 2026-11-04 · the full outcome: get_orderability

Coverage

The issuer's own investor-relations page names 21 research houses: B. Riley Securities, BTIG, Cantor Fitzgerald, Goldman Sachs & Co. LLC, H.C. Wainwright & Co., Jefferies, J.P. Morgan, Lake Street Capital Markets, LLC, Leerink Partners, Maxim Group, Morgan Stanley, Oppenheimer, Raymond James, Stifel, Truist Securities, UBS Securities LLC, William Blair, Wolfe Research, Canaccord Genuity LLC, Laidlaw & Company, and Piper Sandler & Co.

Open research

No openly published research notes were found for the issuer.

Licensed

Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded.

As-of depth

The sealed years that hold the issuer are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12.

Sources

9 source pages are named on this page; every value above carries its own source page and read date in the numbers.

10.1

https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange)

10.2

https://mapping.gleif.org/api/v2/isin-lei/latest (identity.isin)

10.3

https://data.sec.gov/submissions/CIK0001607678.json (identity.jurisdiction)

10.4

https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei)

10.5

https://mcp.us-cm-kg.ai/events/NASDAQ/VKTX (the disclosure lines)

10.6

https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag)

10.7

https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter)

10.8

https://ir.vikingtherapeutics.com/analyst-coverage (coverage)

10.9

https://mcp.us-cm-kg.ai/record/NASDAQ/VKTX (the record)

Read it by agent

The same page, signed and receipted: get_research at https://mcp.getresearch.ai/mcp with {"isin":"US92686J1060"}. Twins: .md · .json. Written: Claude through the platform account, Haiku class; one pass; checked against the numbers. Page hash sha256:27059cb2de675ceb.